• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
[Validity of an indicator of the quality of pharmacological prescription in patients with hyperlipemia].[高脂血症患者药物处方质量指标的有效性]
Aten Primaria. 2001 Mar 31;27(5):308-12. doi: 10.1016/s0212-6567(01)79372-9.
2
[The quality of the drug treatment in hyperlipemia patients from 4 health areas. The VICAF Group].[来自4个健康区域的高脂血症患者的药物治疗质量。VICAF研究组]
Aten Primaria. 2000 Oct 15;26(6):368-73. doi: 10.1016/s0212-6567(00)78685-9.
3
[Definition and validation of quality indicators of prescription in primary care].[基层医疗中处方质量指标的定义与验证]
Aten Primaria. 2006 Mar 31;37(5):273-7. doi: 10.1157/13086314.
4
The cost of inadequate prescriptions for hypolipidaemic drugs. VICAF Group.降血脂药物处方不当的代价。VICAF集团。
Pharmacoeconomics. 2001;19(5 Pt 1):513-22. doi: 10.2165/00019053-200119050-00006.
5
Development of indicators for assessing the quality of prescribing of lipid-lowering drugs: data from the pharmacotherapeutic quality circles in Hesse, Germany.降脂药物处方质量评估指标的制定：来自德国黑森州药物治疗质量改进小组的数据
Int J Clin Pharmacol Ther. 2001 Nov;39(11):492-8.
6
[Impact of a program of rational use of medicines on pharmaceutical prescription in a health area].[合理用药项目对某健康区域药物处方的影响]
Aten Primaria. 1996 Dec;18(10):551-7.
7
[A system, developed by prescribing doctors, of indicators of the quality of pharmaceutical prescription in primary care].[由开处方医生开发的、用于基层医疗中药物处方质量指标的系统]
Aten Primaria. 2003 Nov 15;32(8):460-5. doi: 10.1016/s0212-6567(03)79315-9.
8
[Intervention for improving the quality of antibiotic prescription in a basic health area].[改善基层医疗区域抗生素处方质量的干预措施]
Aten Primaria. 1993 Jan;11(1):37-9.
9
[Prescription and patient-care indicators in healthcare services].[医疗服务中的处方与患者护理指标]
Rev Saude Publica. 2004 Dec;38(6):819-26. doi: 10.1590/s0034-89102004000600010. Epub 2004 Dec 10.
10
[Prescription of drugs in family medicine: on the trail of efficiency].[家庭医学中的药物处方：探寻疗效]
Aten Primaria. 2004 Sep 15;34(4):178-85. doi: 10.1016/s0212-6567(04)78905-2.

引用本文的文献

1
[Definition and validation of quality indicators of prescription in primary care].[基层医疗中处方质量指标的定义与验证]
Aten Primaria. 2006 Mar 31;37(5):273-7. doi: 10.1157/13086314.

本文引用的文献

1
[The quality of the drug treatment in hyperlipemia patients from 4 health areas. The VICAF Group].[来自4个健康区域的高脂血症患者的药物治疗质量。VICAF研究组]
Aten Primaria. 2000 Oct 15;26(6):368-73. doi: 10.1016/s0212-6567(00)78685-9.
2
[Set of indicators for the assessment of the degree to which drug therapy guide is followed in primary care].[基层医疗中药物治疗指南遵循程度评估指标集]
Rev Esp Salud Publica. 2000 Jan-Feb;74(1):65-80.
3
[Analysis of prescriptions in primary care: evaluation of a system of indicators].[基层医疗中的处方分析：指标体系评估]
Aten Primaria. 1997 Oct 31;20(7):381-4.
4
[The validity of therapeutic utility and intrinsic value as indicators of drug prescription quality: an analysis of treatments in cases of the common cold].[治疗效用和内在价值作为药物处方质量指标的有效性：对普通感冒病例治疗的分析]
Aten Primaria. 1997 May 15;19(8):400-6.
5
Cholesterol in the elderly. Is it important?
JAMA. 1994 Nov 2;272(17):1372-4.
6
Criteria for use of hypolipidemic agents in adults.
Am J Hosp Pharm. 1994 Nov 15;51(22):2837-41.
7
Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years.70岁以上人群中胆固醇与冠心病死亡率、发病率及全因死亡率之间不存在关联。
JAMA. 1994 Nov 2;272(17):1335-40.

[高脂血症患者药物处方质量指标的有效性]

[Validity of an indicator of the quality of pharmacological prescription in patients with hyperlipemia].

作者信息

Fernández San Martín M, López Bilbao C, Escortell Mayor E, Sanz Cuesta T, Fidalgo García L, Rodríguez Escolar C

机构信息

Departamento de Ciencias Sanitarias y Médico-Sociales. Universidad de Alcalá. Madrid.

出版信息

Aten Primaria. 2001 Mar 31;27(5):308-12. doi: 10.1016/s0212-6567(01)79372-9.

DOI:10.1016/s0212-6567(01)79372-9
PMID:11333549
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7681371/
Abstract

OBJECTIVES

The computer system for billing prescriptions (SIFAR in Spanish) enables indicators to be extracted for the study and follow-up of the use of medicines in the INSALUD primary care areas. Concretely, we studied the indicator referring to pensioners consumption of lipid-lowering drugs (PCLL), not validated, and whose value is expected to drop as quality increases. The objective was to calculate the correlation of the indicator of prescription of lipid-lowering drugs on the SIFAR with the proportion of lipid-lowerers prescribed correctly for pensioners (PCP).

DESIGN

A descriptive study of correlation between two indicators of drug prescription.

SETTING

Four health districts in Madrid.

PARTICIPANTS

The prescriptions of 49 general practitioners, chosen at random on the basis of three strata defined by the value of the indicator, were studied. Each doctor filled out a protocol of data for each pensioner patient to whom he/she prescribed a lipid-lowerer during the study period.

MEASUREMENTS AND MAIN RESULTS

The PCLL and PCP indicators were compared through the correlation of Spearman. 6,779 prescriptions for 1,125 patients were collected from the 49 participating doctors. The mean percentage of lipid-lowerers correctly prescribed was 31.9%, figure that rose to 77.5% when the LDL value was not specified. The correlation between the PCLL and the PCP was near zero.

CONCLUSIONS

The PCLL indicator of the SIFAR does not discriminate quality in lipid-lowering drug prescription to people over 64.

摘要

目的

处方计费计算机系统（西班牙语为SIFAR）能够提取指标，用于研究和跟踪国家卫生服务局初级保健领域的药物使用情况。具体而言，我们研究了一项针对领取养老金者降脂药物消费情况的指标（PCLL），该指标尚未经过验证，并且预计随着质量的提高其数值会下降。目的是计算SIFAR上降脂药物处方指标与领取养老金者正确开具降脂药物的比例（PCP）之间的相关性。

设计

对两项药物处方指标之间的相关性进行描述性研究。

地点

马德里的四个卫生区。

参与者

根据指标值定义的三个层次随机选择49名全科医生的处方进行研究。每位医生为其在研究期间开具降脂药物的每位领取养老金者患者填写一份数据协议。

测量和主要结果

通过Spearman相关性比较PCLL和PCP指标。从49名参与医生处收集了1125名患者的6779份处方。正确开具降脂药物的平均百分比为31.9%，当未指定低密度脂蛋白值时，这一数字升至77.5%。PCLL与PCP之间的相关性接近零。

结论

SIFAR的PCLL指标无法区分针对64岁以上人群开具降脂药物的质量。